Bromocriptine Mesylate and Methylphenidate Controlled-Release Tablets
Determining the interaction of Bromocriptine Mesylate and Methylphenidate Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Methylphenidate ER Capsules
- Bromocriptine Mesylate-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Bromocriptine Mesylate-Methylphenidate Extended-Release Chewable Tablets
- Bromocriptine Mesylate-Methylphenidate Extended-Release Oral Suspension
- Bromocriptine Mesylate-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Bromocriptine Mesylate-Methylphenidate Extended-Release Tablets
- Methylphenidate Controlled-Release Tablets-Brompheniramine
- Methylphenidate Controlled-Release Tablets-Brompheniramine and codeine
- Methylphenidate Controlled-Release Tablets-Brompheniramine and phenylephrine
- Methylphenidate Controlled-Release Tablets-Brompheniramine and Phenylephrine Chewable Tablets
- Methylphenidate Controlled-Release Tablets-Brompheniramine and Phenylephrine Liquid
- Methylphenidate Controlled-Release Tablets-Brompheniramine and Phenylephrine Suspension